Publications by authors named "H Fehrenbach"

Claim this Profile
H
High adherence to angiotensin-converting enzyme inhibitor in children and adolescents with Alport syndrome: objective verification using liquid chromatography-mass spectrometry.
Jan Boeckhaus, Burkhard Tönshoff, Lutz T Weber, Dieter Haffner, Lars Pape, Henry Fehrenbach

Pediatr Nephrol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA interference medication and transplantation procedures in patients with primary hyperoxaluria type 1 (PH1).
Cristina Martin-Higueras, Lodovica Borghese, Jens König, Caroline Kempf, Britta Höcker, Henry Fehrenbach

Nephrol Dial Transplant· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary Dickkopf-related protein 3 as a novel biomarker for kidney function decline in children with Alport syndrome.
Jan Boeckhaus, Burkhard Tönshoff, Lutz T Weber, Lars Pape, Kay Latta, Henry Fehrenbach

Pediatr Nephrol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ratio of Urinary Proteins to Albumin Excretion Shifts Substantially during Progression of the Podocytopathy Alport Syndrome, and Spot Urine Is a Reliable Method to Detect These Pathologic Changes.
Jan Boeckhaus, Lea Mohr, Hassan Dihazi, Burkhard Tönshoff, Lutz T Weber, Henry Fehrenbach

Cells· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of phospholipid-modified lung surfactant in vitro and in a neonatal ARDS model reveals anti-inflammatory potential and surfactant lipidome signatures.
Sarah Kupsch, Lars F Eggers, Dietmar Spengler, Nicolas Gisch, Torsten Goldmann, Heinz Fehrenbach

Eur J Pharm Sci· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis